Baxter B Timothy
Department of Surgery, University of Nebraska Medical Center and Methodist Hospital, 8111 Dodge St., Suite 220, Omaha, NE 68114, USA.
Am J Surg. 2004 Dec;188(6):628-32. doi: 10.1016/j.amjsurg.2004.08.034.
Aortic aneurysms represent a serious and common condition. Current therapies are based on mechanical treatment. With increased knowledge of the biochemical mechanisms responsible for aneurysm expansion, it may be possible to prevent the growth of small aneurysms.
A series of experiments performed in the investigator's laboratory during the past decade is outlined to show the evolution of our concepts of the processes underlying aneurysm formation and progression.
Our understanding of aortic aneurysms has changed dramatically. Once thought to represent a simple degenerative process, aneurysm tissue is highly active metabolically with ongoing synthesis and degradation of matrix proteins. Several members of a family of matrix-degrading enzymes play an important role in this process. These enzymes can be inhibited by the antibiotic doxycycline.
With a better understanding of aneurysm pathology, it may be possible in the future to inhibit the growth of small aortic aneurysms before they reach a size at which the risk of rupture is significant.
主动脉瘤是一种严重且常见的病症。当前的治疗方法基于机械治疗。随着对导致动脉瘤扩张的生化机制的了解不断增加,有可能预防小动脉瘤的生长。
概述了过去十年在研究者实验室进行的一系列实验,以展示我们对动脉瘤形成和进展过程的概念演变。
我们对主动脉瘤的理解发生了巨大变化。动脉瘤组织曾经被认为是一个简单的退行性过程,现在发现其代谢高度活跃,伴随着基质蛋白的持续合成和降解。一个基质降解酶家族的几个成员在这个过程中起重要作用。这些酶可被抗生素强力霉素抑制。
随着对动脉瘤病理学的更好理解,未来有可能在小主动脉瘤达到破裂风险显著的大小之前抑制其生长。